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transcriptome; branched-chain amino acid; KLF15; ILK signaling; micro-RNA-1 ADULT SKELETAL MUSCLE MASS is primarily dictated by the net balance between the rates of protein synthesis and degradation. It is well established that muscle hypertrophy is the result of a sustained, net increase in the rate of protein synthesis that ultimately leads to the accretion of myofibrillar protein (7) . Over the last decade, great strides have been made in defining the signaling pathways that control protein synthesis, as exemplified by the identification of the insulin-like growth factor I/Akt/mechanical target of rapamycin (mTOR) complex 1 (mTORC1) signaling pathway and its central role in the regulation of muscle hypertrophy (1) . Although gene expression during skeletal muscle hypertrophy has been well studied, to our knowledge, only a few studies using microarray technology have performed a limited temporal (two time points) transcriptome analysis (16, 17, 22, 26, 29) . Studies using microarray analysis are important because they provide an unbiased analysis of the biological processes that are operative during muscle hypertrophy, thereby allowing for the identification of genes and pathways not previously recognized as having a role in skeletal muscle growth. The purpose of this study was to perform a comprehensive transcriptome analysis by collecting data at multiple time points during the hypertrophic response induced by synergist ablation. We used this model of muscle hypertrophy because it induces a robust and progressive increase in muscle mass (18, 20, 30) . The primary goal of performing a time course analysis was to identify signaling pathways that are operative throughout the hypertrophic response. In addition, we view this annotated transcriptome data set as a valuable resource for researchers with an interest in skeletal muscle plasticity.
The global gene expression patterns were determined using a microarray analysis after 1, 3, 5, 7, 10 , and 14 days of functional overload in mouse plantaris muscle. We used two parameters, principal component analysis (PCA) of gene expression and the number of differentially expressed genes, to define three gene expression patterns of the hypertrophic response: early (1 day), intermediate (3, 5 , and 7 days), and late (10 and 14 days) patterns. Moreover, the analysis of the canonical pathways revealed the involvement of specific pathways at each gene expression pattern in response to mechanical overload. We identified 1) several pathways associated with the immune response and injury/disease during the early gene expression pattern; 2) a number of pathways related to metabolism, mechanotransduction, and mitochondrial function during the intermediate gene expression pattern; and 3) one pathway related to blood coagulation during the late gene expression pattern. In particular, we identified valine degradation and integrin-linked kinase (ILK) pathways as potentially important to cell growth, although little is known about their possible role in skeletal muscle hypertrophy. The informatics analysis led to the identification of the transcription factor Klf15 (Kruppel-like factor-15) and the micro-RNA-1 (miR-1) as two potential upstream regulators of valine degradation and ILK pathways, respectively.
MATERIAL AND METHODS

Animal Care and Use
All experimental procedures performed in this study were approved by the University of Kentucky Institutional Animal Care and Use Committee. Male C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME), 5 mo of age, were housed in a temperature-and humidity-controlled facility on a 14:10 h light-dark cycle with access to food and water ad libitum. The bilateral synergist ablation model was used to induce hypertrophy of the plantaris muscle, as previously described (19) . Briefly, a small incision was made on the dorsal aspect of the lower hindlimb of a continually anesthetized mouse (2% isoflurane at 0.5 l/min), and the entire soleus was carefully removed along with the majority of the gastrocnemius muscle. Particular attention was made to ensure that the neural and vascular supply of the plantaris muscle was not damaged during the excision of the synergist muscles. Following recovery from surgery, mice were anesthetized at the designated time point by an intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg), and plantaris muscles were excised, weighed, placed in RNAlater (Ambion, Austin, TX), and stored at 4°C until use. Plantaris muscle was collected at 1, 3, 5, 7, 10, and 14 days after the surgery (d1, d3, d5, d7, d10, and d14, respectively; n ϭ 6 per group). Control plantaris muscle (n ϭ 6) was collected from mice subjected to a sham synergist ablation surgery. Following collection of the plantaris muscle, mice were killed by cervical dislocation under anesthesia.
RNA Isolation
Total RNA was prepared from plantaris muscle using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's directions. RNA samples were treated with TURBO DNase (Ambion, Austin, TX) to remove genomic DNA contamination. The total RNA concentration and purity were assessed by measuring the optical density (230, 260, and 280 nm) with the Nanodrop 1000 Spectrophotometer (ThermoFisher Scientific, Wilmington, DE). RNA integrity was assessed using the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA); the average RNA integrity number value for all samples was 9.46 Ϯ 0.10 (scale 1-10), indicating high-quality RNA with minimal degradation products.
Microarray and Microarray Data Analysis
The microarray hybridization and processing were performed at the University of Kentucky Microarray Core Facility, according to the manufacturer's protocol (Affymetrix, Santa Clara, CA). For each time point, two Affymetrix chips (mouse gene 1.0 ST) were used with 250 ng of total RNA derived from a pooled sample of either the right or left plantaris muscles from six animals. We pooled RNA samples based on the experimental results reported by Kendziorski et al. (12) , showing that gene expression from RNA pools are similar to averages of individuals that comprise the pool. The mouse gene 1.0 ST chip provides coverage of 28,000 protein coding transcripts and 7,000 noncoding transcripts of which ϳ2,000 are long intergenic noncoding transcripts. Then the gene expression obtained from the two chips (replicates of the pooled RNA samples from the same animals, with each pooled sample derived from separate plantaris muscles) at each time point was averaged and uploaded to Partek Genomics Suite (St. Louis, MO) to identify differentially expressed genes; the criteria for a gene to be considered differentially expressed was a twofold or greater increase or a Ն50% decrease in expression in the experimental group relative to the control group. At this step, we did not set a lower cutoff for the signal intensity to avoid excluding low expressed genes that might show a significant upregulation in response to functional overload. All of the microarray data obtained in this study are available by using GEO accession number GSE47098 (available at http://www.ncbi.nlm.nih.gov/geo). Ingenuity Pathway Analysis (IPA; Ingenuity Systems, Redwood, CA) was then used to identify those pathways that were significantly enriched in the list of differentially expressed genes associated with skeletal muscle. The IPA program is based on the Ingenuity Knowledge Base, which consists of millions of relationships (between genes, protein complexes, and networks) extracted from peer-reviewed scientific literature (2) . As miR-1 was identified by IPA to target some upregulated transcripts associated with ILK signaling (see RESULTS) , we expanded our analysis and confirmed this prediction by using the online miRNA database TargetScan 6.2 (14) .
cDNA Synthesis and RT-PCR
Reverse transcription was performed using 1 g of total RNA (n ϭ 6 at each time point) with oligo(dT) primer and Superscript III reverse transcriptase (Invitrogen, Carlsbad, CA), according the manufacturer's instructions. Taqman probe and primers for quantitative PCR (qPCR) reactions were obtained from Applied Biosystems as follows: Klf15, Mm00517792_ m1; Bcat2, Mm00802192_m1; Ehhdah, Mm00619685_m1; Parva, Mm00480444_m1; Snai2, Mm00441531_m1; Gapdh, Mm99999915_g1; Rpl38, Mm03015864_g1; Ddit4, Mm00512504_g1. qPCR was performed using Taqman Gene Expression Master Mix (2ϫ) (Invitrogen, Carlsbad, CA), using 5 l of diluted cDNA (1/10 dilution from stock cDNA mixture) and 1 l of primer mix in a 20-l final volume. qPCR were performed using an ABI 7500 RT-PCR system (Invitrogen).
miR-1 detection. Reverse transcription was performed with 20 ng of total RNA (n ϭ 6 at each time point) using the miRCURY LNA Universal RT micro-RNA PCR kit (Exiqon, Woburn, MA), according to the manufacturer's instructions. A synthetic spike-in template (UniSp6) was added during the RT step to control for the efficiency of cDNA synthesis and micro-RNA qPCR. qPCR was carried out with Power SYBR Green PCR Master Mix (2ϫ) (Invitrogen) using 4 l of diluted cDNA (1/40 dilution from stock cDNA mixture) and 2 l of primer mix from Exiqon (miR-1, no. 204344; UniSp6, no. 203450) in a 20-l final volume. qPCR were performed using ABI 7500 RT-PCR system according to Exiqon's instructions.
mRNA and micro-RNA quantification. Quantification cycles (Cq) were determined by ABI 7500 software version 2.0.1. Absolute quantification was achieved by exponential conversion of the Cq using the qPCR efficiency. qPCR efficiency was estimated from standard curves obtained by serial dilutions (1-log range) of a pooled sample for each RT set (23) . Relative quantification of the target mRNA was obtained after the normalization with the geometric mean of exponential conversion of the Cq of three reference genes (Rpl38, Gapdh, and Ddit4). The geometric mean based on these genes was not affected by mechanical overload over time. Relative quantification of the miR-1 was obtained after the normalization with UniSp6. We chose to use this external normalization method because we were unable to identify a constant reference gene for internal normalization (data not shown).
Statistical Analysis
A right-tailed Fisher's exact test was used to determine the top statistically significant canonical pathways from IPA. For this analysis, a P value Ͻ 0.001 was considered statistically significant. The total RNA concentration and qPCR data are presented as means Ϯ SE. Multigroup comparisons were performed by one-way ANOVA followed by Tukey's post hoc test. For the ANOVA analysis, the level of statistical significance was set at P Ͻ 0.05.
RESULTS
Skeletal Muscle Hypertrophy Is Associated With Increased Total RNA Content
In an effort to perform a comprehensive transcriptome analysis of adult skeletal muscle during hypertrophic growth, we carried out a time course of 1, 3, 5, 7, 10, and 14 days following synergist ablation. As our laboratory previously reported, there was a significant and progressive increase in plantaris muscle mass during mechanical overload (20) . The total RNA content progressively increased between 3 and 7 days of hypertrophy (0.86 Ϯ 0.07, 1.54 Ϯ 0.12, and 2.36 Ϯ 0.14 g/mg muscle after 3, 5, and 7 days of hypertrophy, respectively) and then stabilized through d14.
Identification of Specific Gene Expression Patterns During Skeletal Muscle Hypertrophy
To obtain a more global perspective on the variance in gene expression across the time course, PCA was performed using Partek Genomics Suite. PCA revealed that 68% of the variation in gene expression was accounted for by the first two principal components (Fig. 1) . The distribution of each group along the first component (x-axis, PC #1) indicated the imposition of synergist ablation had the greatest effect on gene expression variability. This is clearly shown by the distinct separation of the control group from all of the experimental groups. The distribution of groups along the second component (y-axis, PC #2) suggested that the length of time that synergist ablation was applied had the second greatest influence on the variability of gene expression. Thus PCA provided evidence that the two independent variables (synergist ablation and time) were the primary source of variability in gene expression. The clustering of the experimental groups along PC #2 supports the concept of an early (d1), intermediate (d3-7), and late (d10 -14) gene expression patterns of the hypertrophic response.
Next, we used IPA software to filter the differentially expressed genes (cutoffs Ͼ2-fold or Ͻ50%) associated with skeletal muscle. As shown in Fig. 2 , ϳ1,050 genes were differentially expressed at d1, a number that progressively increased from d3 to reach ϳ1,700 genes at d7 and then decreased, becoming the lowest at d14. The proportion of upregulated genes was higher than that of downregulated genes at d1, d10, and d14, whereas the proportion of up-and downregulated genes was similar between d3 and d7. Taken together, the results from the PCA and the pattern of change in the number of differentially expressed genes provide parameters to assign three gene expression patterns for the hypertrophic response during mechanical overload as: early (1 day), intermediate (3, 5 , and 7 days), and late (10 and 14 days) patterns.
Canonical Pathways Identified During the Early, Intermediate, and Late Gene Expression Patterns of Skeletal Muscle Hypertrophy
Using the differential gene expression lists, we applied IPA to determine the enriched canonical pathways in skeletal muscle during mechanical overload. The number of canonical pathways that were significantly (P Ͻ 0.001) enriched was the highest at d1 (29) and then progressively decreased at each subsequent time point (20, 19, 13, 11 , and 9 at d3, d5, d7, d10, and d14, respectively). In Fig. 3 , we only presented the enriched pathways specific to each gene expression pattern (early, intermediate, and late) and those common across the entire time course. There were four pathways that were enriched across all three gene expression patterns of the time course: hepatic fibrosis/hepatic stellate cell activation, T-helper cell differentiation, LPS/IL-1-mediated inhibition of retinoid X receptor (RXR) function and liver X receptor (LXR)/RXR activation. The exact role of these pathways in the hypertrophic response in skeletal muscle is not readily apparent, as they have been primarily shown in the liver to regulate the production of connective tissue (hepatic fibrosis/hepatic stellate cell activation and T-helper cell differentiation) (10, 11), cholesterol metabolism (LPS/IL-1 mediated inhibition of RXR function and LXR/RXR activation) (3, 34) , and inflammation (T-helper cell differentiation) (11) .
Thirteen pathways were specifically enriched during the early gene expression pattern of hypertrophy, in which the majority of genes were upregulated. Most of these pathways were categorized as the immune response (7) and disease (3), while two nuclear receptor (peroxisome proliferator-activated receptor signaling and vitamin D receptor/RXR activation) and one cellular stress-related (p38 MAPK signaling) signaling pathways were activated. The activation of the immune system as represented by pathways such as inducible nitric oxide synthase, IL-6, and nuclear factor-B signaling more than likely reflects the acute inflammatory response to muscle injury resulting from mechanical overload (13) . However, the prolonged upregulation of T helper cell differentiation pathway across the entire time course suggests that the immune response is still active even after the initial muscle injury has been repaired. The importance of the T-helper cell differentiation pathway to muscle hypertrophy remains to be understood. During the intermediate gene expression pattern (d3-d7), metabolic pathways involving mitochondria function (mitochondrial dysfunction) and energetic metabolism (TCA cycle and valine degradation) were enriched. Noteworthy, most of the genes related to these metabolic pathways were downregulated. In contrast, at this same time period, the genes associated with the ILK signaling pathway were generally upregulated. Only intrinsic prothrombin activation pathway was specifically enriched during the late gene expression pattern (d10 -d14) of hypertrophy. This pathway related to blood coagulation, which may reflect a late adaptation of blood vessels/capillarity in response to muscle injury, is not clearly understood during hypertrophic growth.
Given the progressive increase in total RNA content observed between 3 and 7 days following synergist ablation, certainly reflecting an increase in ribosome content associated with increased protein synthesis (20) , and the robust change in gene expression during this time period (Fig. 2) , we chose to focus on the pathways enriched during the intermediate gene expression pattern of hypertrophy. Surprisingly, we did not identify any enriched signaling pathways directly related to mTORC1, a central regulator of protein synthesis during skeletal muscle hypertrophy. We focused our attention on valine degradation and ILK pathways. These two pathways stood out because ILK signaling regulates gene expression via mechanotransduction, and valine degradation is involved in branched-chain amino acid (BCAA) availability, two processes potentially involved in muscle growth (24, 35) .
Valine Degradation Pathway
IPA software specifically identified, during the intermediate gene expression pattern of hypertrophy, the BCAA pathway related to valine degradation. The two other pathways associated with BCAA degradation, the isoleucine and leucine degradation pathways, were not significant at P Ͻ 0.001, but were significantly downregulated at a P Ͻ 0.05 at d3 for leucine degradation pathway and d3 through d7 for isoleucine degradation pathway. These three BCAA degradation pathways are characterized by a few common enzymatic complexes: BCAA transaminase catalyzes the first enzymatic reaction of the three BCAA degradation pathways, while two other enzymatic complexes (2-methylacyl-CoA dehydrogenase and enol-CoA hydratase) are common to both valine and isoleucine degradation pathways.
As presented in Table 1 , 11 genes were downregulated at least one time between d3 and d7 of mechanical overload. These genes exclusively encoded components of enzymatic complexes (dehydrogenase, transaminase, hydrolase and hydratase) that are present at the different steps of valine degradation pathway (Fig. 4) . Moreover, six of these genes (Auh, Bcat2, Dld, Ehhadh, Hadha, and Hadhb) were also components of the isoleucine degradation pathway, while Auh and Bcat2 were part of the leucine degradation pathway. Two other genes specifically associated with leucine degradation pathway (Acadm and Mcc2) were also downregulated between d3 and d7 (data not shown). These results clearly suggest that the BCAA degradation pathway is significantly downregulated during the intermediate gene expression pattern of the hypertrophic response. The downregulation of the BCAA degradation pathway suggested expression of pathway components was coordinated through the use of a common upstream regulator. In support of this idea, IPA revealed that the components of both the valine and isoleucine degradation pathway Ehhadh, Hadha, and Hadhb, and the component of leucine degradation pathway Acadm were all potential targets of the transcription factor Klf15. Consistent with such a mechanism, microarray analysis showed that Klf15 mRNA expression was decreased by ϳ60% between d3 and d7 of overload compared with control muscles, similar to the The nos. represent the fold change of gene expression after 3, 5 and 7 days (d3, d5, d7, respectively) of mechanical overload compared with control non-overloaded muscles. Italicized numbers mean that the fold change in gene expression is lower than 50% decrease. The selected genes were differentially expressed (twofold increase or 50% decrease) at least one time between d3 and d7. *Genes also associated with the isoleucine degradation pathway. †Genes also associated with the leucine degradation pathway. Table 1. decreased expression of Ehhadh, Hadha, and Hadhb (Table 1) and of Acadm (about Ϫ70% between d3 and d7). Moreover, Shimizu et al. (28) recently demonstrated that Klf15 activation was associated with the upregulation of Bcat2, a member of BCAA transaminase that catalyzes the initial step of degradation for all three of the BCAAs in skeletal muscle. To confirm our array results, qPCR were performed to assess the mRNA expression of Klf15, Bcat2, and Ehhdah. Ehhdah was chosen for validation because it is a common member of enoyl-CoA hydratase with Hadha and Hadhb. In agreement with the array findings, the expression of these three genes was decreased in response to mechanical overload, with the greatest change observed for Klf15 (Fig. 5) . The decreases in mRNA expression were ϳ90%, 42-53%, and 44 -73% between 3 and 7 days of overload for Klf15, Bact2, and Ehhdah, respectively.
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ILK Pathway
Another pathway that was found to be enriched during the intermediate gene expression pattern was the ILK pathway. The differentially expressed genes related to the ILK signaling are presented in Table 2 . Among the 50 genes that were differentially expressed at least one time between d3 and d7 of mechanical overload, 36 (72%) were upregulated, whereas 14 (28%) were downregulated. These genes mainly encoded proteins related to the cytoskeleton and sarcomeric proteins, enzymes, kinases, phosphatases, and transcription regulators. As shown in Fig. 6 , which was derived from our IPA analysis, ILK is activated upstream by extracellular matrix (ECM) proteins and growth factors via integrin-␤ complex and receptor tyrosine kinase/insulin receptor substrate/phosphoinositide 3-kinase signaling, respectively, as well as directly by parvin-␣ (27) . Once activated, ILK regulates a number of biological process, including cytoskeleton dynamics, ECM composition, sarcomere protein expression, and cell proliferation.
Ingenuity Knowledge Base revealed that five of the upregulated genes (Ccnd1, Fn1, Parva, Pik3ca2, and Snai2) were predicted targets of miR-1, a muscle-specific micro-RNA previously reported to be downregulated in this model of muscle hypertrophy (19) . The online algorithm TargetScan (http:// www.targetscan.org) confirmed that these genes are predicted targets of miR-1. To confirm that the upregulation of these genes correlates with the downregulation of miR-1, qPCR was performed. We chose to assess the mRNA expression of Parva because it is a central regulator of ILK signaling, and Snai2 because it is a transcription factor that regulates the expression of the ECM protein fibronectin (Fn1) (Fig. 7) . As illustrated in Fig. 7 , Parva and Snai2 mRNA were increased in response to mechanical overload, particularly after d7 (3.46-and 3.91-fold increase, respectively). In contrast, the expression of miR-1 was markedly reduced from d3 of overload, reaching a 73% decrease at d7 (Fig. 7) . These results show that miR-1 downregulation correlates with the upregulation of two of its predicted targets and suggest that miR-1 may regulate ILK signaling during skeletal muscle hypertrophy.
DISCUSSION
This study was designed to identify putative intracellular signaling pathways and molecular regulators involved in functional overload-induced skeletal muscle hypertrophy through a temporal transcriptome analysis. The major findings of the study are the following: 1) based on gene expression variability as assessed by PCA and the number of differentially expressed genes, three (early, intermediate, and late) gene expression patterns could be distinguished during skeletal muscle hypertrophy; 2) we identified several significant signaling pathways restricted to each particular gene expression pattern: some pathways were associated with immune response and injury/ disease (early gene expression pattern), metabolism, mechanotransduction, and mitochondrial function (intermediate gene expression pattern), and one pathway was related to blood coagulation (late gene expression pattern); 3) during the intermediate gene expression pattern (d3-d7), many components of the BCAA degradation pathway were significantly downregulated, in particular the valine degradation pathway, while the ILK pathway was upregulated; 4) the Klf15 transcription factor was identified as a putative regulator of the BCAA degradation pathway, and changes in expression of the muscle-specific miR-1 are linked to regulation of the ILK signaling.
The PCA results and the number of differentially expressed genes allowed us to identify three gene expression patterns during hypertrophy: early (d1), intermediate (d3-d7), and late (d10 -d14) patterns. IPA also revealed the presence of several enriched pathways at each specific gene expression pattern (Fig. 3) . Not surprising is the finding that the early response was characterized by the activation of pathways related to immune response and disease. This finding probably results from the infiltration of immune cells into skeletal muscle tissue in response to muscle ablation and/or muscle damage induced by overload. We did not focus our attention on these pathways because their activation is more than likely specific to this "supra" physiological model of muscle hypertrophy. In this study, we showed that 1) overload resulted in a progressive increase in the total RNA content between d3 and d7, which presumably indicates large increases in ribosomal RNA and content at a time associated with increased rates of protein synthesis (20) ; and 2) the most robust change in gene expression (assessed by the number of differentially regulated genes, Fig. 2 ) was observed during this intermediate gene expression pattern. Therefore, we chose to focus our attention on this Here, we showed that several components of the valine degradation pathway are downregulated during the intermediate gene expression pattern in response to mechanical overload (Table 1) . Interestingly, some of these genes also encode The nos. represent the fold change of gene expression after d3, d5, and d7 of mechanical overload compared with control non-overloaded muscles. Italicized numbers mean that the fold change in gene expression is either lower than 50% decrease or lower than 2-fold increase. The selected genes were differentially expressed (twofold increase or 50% decrease) at least one time between d3 and d7. components essential for the degradation of leucine and isoleucine, the two other BCAAs. Moreover, we showed that mRNA expression of the transcription factor Klf15 is significantly downregulated during hypertrophy, which correlated with the reduced expression of four of its IPA-predicted targets: Ehhadh, Hadha, and Hadhb (3 components of enoyl-CoA dehydrogenase, a valine and isoleucine-degrading enzymatic complex), and Acadm (a component of a leucine-degrading enzymatic complex). In addition to these genes, Bcat2, which encodes the protein that catalyzes the initial step for the degradation of all BCAAs, is also downregulated with hypertrophy and has been reported to be regulated by Klf15 in skeletal muscle (28) .
There is accumulating evidence that Klf15 is capable of influencing muscle mass by regulating the expression of genes that are part of the BCAA degradation pathway. The inactivation of Klf15 resulted in a modest but significant increase in lean mass that was associated with a reduced expression of multiple genes encoding amino acid-degrading enzymes, including Bcat2 (8) . However, a more recent study from this same group reported no change in skeletal muscle mass (9) , while Klf15 null mice developed a severe cardiac hypertrophy in response to pressure overload (6) . Alternatively, Klf15 overexpression was shown to accelerate catabolism of BCAA, resulting in myotube and skeletal muscle atrophy (28) . Elevated levels of Klf15 also suppressed mTOR activity in myotubes (28), a central regulator of protein synthesis shown to be . Schematic representation of the ILK signaling and its putative regulation by the micro-RNA-1 (miR-1). This pathway was adapted from the pathway determined by Ingenuity Pathway Analysis and represents the main genes differentially regulated in response to 3-7 days of mechanical overload. The gene expression of these components of ILK signaling was determined by microarray and is presented in Table 2 . As shown in Table 2 , the gene expression of two members of insulin receptor substrate (IRS) family, IRS1 and SH2B2, is decreased and increased, respectively (represented by green in the figure). The gene expression of some components of myosin is either increased or decreased (represented by green in the figure; gene expression presented in Table 2 ). The genes designated in purple are predicted targets of miR-1. ECM, extracellular matrix; PARVA, parvin-␣; RTK, receptor tyrosine kinase; PI3K, phosphoinositide 3-kinase; GSK3, glycogen synthase kinase 3; FN1, fibronectin 1; SNAI2, snail homolog 2; CTN-␤, ␤-catenin; CCND1, cyclin D1; MYC, v-myc myelocytomatosis viral oncogene homolog. activated during overload-induced muscle hypertrophy (1, 20, 25) . Currently, it is difficult to accurately determine the localization and expression of KLF15 protein in skeletal muscle. Although the involvement of KLF15 in skeletal muscle hypertrophy remains unclear, our computational analysis suggests that the decreased expression of Klf15 in response to overload may contribute to the downregulation of genes that are involved in the degradation of BCAAs. Under such a scenario, intracellular BCAAs may be elevated and contribute to the prolonged activation of mTORC1 considered necessary for muscle hypertrophy. In addition to its role in amino acid metabolism, Klf15 was recently shown to regulate lipid flux in skeletal muscle (9) ; thus, it is not know if these different functions (regulation of lipid and amino acid metabolism) of Klf15 are uncoupled during skeletal muscle hypertrophy.
In addition to the BCAA degradation pathway, we also identified ILK signaling as a robustly regulated pathway during the intermediate gene expression pattern of hypertrophy. ILK is a serine/threonine kinase that links integrins with the forcegenerating actin cytoskeleton. As illustrated in Fig. 6 , this kinase coordinates cues from ECM, including distinct signal inputs from integrins and growth factor receptor tyrosine kinases. This signaling was shown to regulate the cellular structural integrity and homeostasis in skeletal and cardiac muscle (31, 32) . The inactivation of ILK results in the loss of structural integrity in cardiac muscle (32) , while it does lead to the development of a mild progressive muscular dystrophy, characterized by extensive fibrosis and irregular fiber size with centralized nuclei in skeletal muscle (31, 32) . Although it remains to be elucidated, the activation of ILK signaling could contribute to the protection of skeletal muscle from overloadinduced damage, which is clearly observed 7 days following mechanical overload in this model of hypertrophy (18) . Studies have also provided evidence to suggest that ILK could play a role in the regulation of the Akt/mTOR signaling in striated muscle, although these findings remain controversial (15, 31, 32) . These findings support the idea that the ILK pathway is involved in the regulation of muscle remodeling and structural integrity in response to compensatory overload, as well as possibly contributes to the increase in protein synthesis resulting from mTORC1 activation.
Our analysis revealed that changes in expression of the muscle-specific miR-1 may contribute to ILK signaling. MicroRNAs are small noncoding RNAs that repress gene expression by binding to sequences in the 3=-untranslated region of gene leading to the inhibition of translation and/or degradation of the transcript (21) . We showed that the marked decrease in miR-1 expression with hypertrophy is associated with increased expression of five predicted target genes that are part of the ILK signaling pathway. In particular, we confirmed that miR-1 expression was significantly reduced, while the expression of two upstream activators of ILK, the ILK-binding protein Parva (27) , and Pik3ca2, a subunit of phosphoinositide 3-kinase, were upregulated, a finding consistent with micro-RNA function. The loss of miR-1 expression may also have contributed to the increased expression of another target gene within the ILK pathway, Snai2; Snai2 is a transcription factor that regulates the expression of the ECM-related protein Fn1. As a confirmed target of miR-1, the upregulation of Ccnd1 expression during hypertrophy is likely, in part, the result of the decrease in miR-1 expression (33). Altogether, our results suggest that, in addition to mechanical signals and growth factors, miR-1 may regulate ILK signaling during skeletal hypertrophy. This finding, in addition to the observation that miR-1 is downregulated in response to resistance exercise in young humans (4) , suggest that miR-1 could play a central role in the control of the skeletal muscle mass.
In conclusion, we identified in this study two novel pathways that may be involved in muscle hypertrophy during mechanical overload. The enzyme-related genes involved in BCAA degradation (especially valine degradation) are downregulated during the intermediate gene expression pattern of overload-induced hypertrophy, and this could be partly due to downregulation of the transcription factor Klf15. This finding suggests that the downregulation of genes involved in the degradation of BCAAs could enhance its availability, modulate mTORC1 signaling, and contribute to the increase in protein synthesis in response to a hypertrophic stimulus. We also showed that the ILK signaling pathway is activated during the intermediate gene expression pattern in response to mechanical overload. This mechanical stress-associated pathway may have a central role in cytoskeleton integrity and remodeling in response to mechanical overload, as well as contribute to the activation of mTORC1 signaling. Our findings also support the notion that the downregulation of miR-1 in response to mechanical overload promotes the activation of the ILK pathway. The identification of Klf15 and miR-1 as two upstream regulators of BCCA degradation and ILK pathway, respectively, provides targets for future studies investigating the importance of these pathways in muscle hypertrophy.
